Brevan Howard Capital Management LP Edgewise Therapeutics, Inc. Transaction History

Brevan Howard Capital Management LP

  • $17 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$11.42 - $20.13 $154,866 - $272,982
13,561 New
13,561 $177,000
Q4 2024

Feb 14, 2025
BUY
$26.63 - $36.62 $375,349 - $516,158
14,095 Added 125.28%
25,346 $676,000
Q3 2024

Nov 14, 2024
BUY
$15.88 - $29.5 $178,665 - $331,904
11,251 New
11,251 $300,000

Others Institutions Holding EWTX

# of Institutions
184
Shares Held
112M
Call Options Held
188K
Put Options Held
121K
View Full List

About Edgewise Therapeutics, Inc.

EWTX Quotes by TradingView
  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $1.44B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email